Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poliorix and Infanrix co-administration in primary infant immunization in Russia
2013-002804-15Phase 4
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Poliorix and acellular pertussis vaccine in poliomyelitis, diphtheria, Tetanus and 1 more, sponsored by GSK. Primary endpoints: Occurrence of solicited local adverse events and Occurrence of solicited general adverse events.
02
Drugs
Poliorixacellular pertussis vaccine
03
Conditions
poliomyelitisdiphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2013-002804-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002804-15.